肠道菌群与冠心病的相关关系研究
Study on the Relationship between Intestinal Flora and Coronary Heart Disease
DOI: 10.12677/ACM.2022.1291274, PDF,   
作者: 段豪亮:青海大学,青海 西宁
关键词: 肠道菌群冠心病联系Intestinal Flora Coronary Heart Disease Connection
摘要: 人体内居住着大量的微生物,其中大部分位于胃肠道,人类的胃肠道中有着1013~1014种细菌(即肠道菌群),肠道菌群在人体形成一个庞大而复杂的微生态系统。在参与能量代谢、调节免疫、营养循环及人类健康和疾病方面发挥着重要的作用。人体肠道系统的变化会影响新陈代谢,并可能导致疾病的发生。近年来,国内外研究发现肠道菌群在心脑血管尤其与冠心病密切相关,一些研究已经确定了冠心病患者肠道微生物群组成和代谢的特征性变化。肠道菌群及代谢产物在冠心病诊断、治疗、预后方面也起着重要作用。或许在不久的将来,肠道菌群在疾病的诊断、治疗、预防等方面的作用将会对人类医学进步产生重要意义。此篇文章阐述了近年来的一些相关研究,为下一步研究肠道菌群与冠心病的关系及预防冠心病的发生、发展提供一些新思路、新想法。
Abstract: There are a large number of microorganisms living in the human body, most of which are located in the gastrointestinal tract. There are 1013~1014 kinds of bacteria (intestinal flora) in the human gas-trointestinal tract. Intestinal floras form a huge and complex micro-ecosystem in the human body. It plays an important role in participating in energy metabolism, regulating immunity, nutrient cy-cling and human health and disease. Changes in the human gut system can affect metabolism and can lead to disease. In recent years, domestic and foreign studies have found that the gut microbiota is closely related to coronary heart disease, especially in the cardiovascular and cerebrovascular disease. Some studies have identified the characteristic changes in the composition and metabolism of the gut microbiota in patients with coronary heart disease. Intestinal flora and metabolites also play an important role in the diagnosis, treatment and prognosis of coronary heart disease. Perhaps in the near future, the role of gut microbiota in the diagnosis, treatment, and prevention of diseases will be of great significance to the progress of human medicine. This article describes some related research in recent years, and provides some new ideas for the next step to study the relationship between intestinal flora and coronary heart disease and to prevent the occurrence and develop-ment of coronary heart disease.
文章引用:段豪亮. 肠道菌群与冠心病的相关关系研究[J]. 临床医学进展, 2022, 12(9): 8823-8830. https://doi.org/10.12677/ACM.2022.1291274

参考文献

[1] Belkaid, Y. and Hand, T.W. (2014) Role of the Microbiota in Immunity and Inflammation. Cell, 157, 121-141. [Google Scholar] [CrossRef] [PubMed]
[2] Qin, J., et al. (2010) A Human Gut Microbial Gene Catalogue Es-tablished by Metagenomic Sequencing. Nature, 464, 59-65. [Google Scholar] [CrossRef] [PubMed]
[3] Li, J., et al. (2014) An Integrated Catalog of Reference Genes in the Human Gut Microbiome. Nature Biotechnology, 32, 834-841. [Google Scholar] [CrossRef] [PubMed]
[4] Fassarella, M., Blaak, E.E., Penders, J., et al. (2021) Gut Microbiome Stabil-ity and Resilience: Elucidating the Response to Perturbations in Order to Modulate Gut Health. Gut, 70, 595-605. [Google Scholar] [CrossRef] [PubMed]
[5] Rinninella, E., Cintoni, M., Raoul, P., et al. (2019) Food Compo-nents and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. Nutrients, 11, Article No. 2393. [Google Scholar] [CrossRef] [PubMed]
[6] Fihn, S.D., Gardin, J.M., Abrams, J., Berra, K., Blankenship, J.C., Dallas, A.P., et al. (2012) 2012 ACCF/AHA/ACP/ AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association T Ask Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and In-terventions, and Society of Thoracic Surgeons. JACC: Journal of the American College of Cardiology, 60, e44-e164.
[7] Backhed, F., et al. (2004) The Gut Microbiota as an Environmental Factor That Regulates Fat Storage. Proceedings of the National Academy of Sciences of the United States of America, 101, 15718-15723. [Google Scholar] [CrossRef] [PubMed]
[8] Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I. (2006) An Obesity-Associated Gut Microbiome with Increased Capacity for Energy Harvest. Na-ture, 444, 1027-1031. [Google Scholar] [CrossRef] [PubMed]
[9] Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I. (2006) Microbial Ecology: Human Gut Microbes Associated with Obesity. Nature, 444, 1022-1023. [Google Scholar] [CrossRef] [PubMed]
[10] den Besten, G., Lange, K., Havinga, R., van Dijk, T.H., et al. (2013) Gut-Derived Short-Chain Fatty Acids Are Vividly As-Similated into Host Carbohydrates and Lipids. The American Journal of Physiology-Gastrointestinal and Liver Physiology, 305, G900. [Google Scholar] [CrossRef] [PubMed]
[11] Flint, H.J., Scott, K.P., Duncan, S.H., Louis, P. and Forano, E. (2012) Microbial Degradation of Complex Carbohydrates in the Gut. Gut Microbes, 3, 289-306. [Google Scholar] [CrossRef] [PubMed]
[12] Geurts, L., Lazarevic, V., et al. (2011) Altered Gut Microbiota and Endo-cannabinoid Systemtone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue. Frontiers in Microbiology, 2, Article No. 149. [Google Scholar] [CrossRef] [PubMed]
[13] Cani, P.D., Osto, M., Geurts, L. and Everard, A. (2012) Involvement of Gut Micro-Biota in the Development of Low- Grade Inflammation and Type 2 Diabetes Associated with Obesity. Gut Microbes, 3, 279-288. [Google Scholar] [CrossRef] [PubMed]
[14] Muccioli, G.G., Naslain, D., Bäckhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M., et al. (2010) The Endocannabinoid System Links Gut Micro-Biota to Adipogenesis. Molecular Systems Biology, 6, Article No. 392. [Google Scholar] [CrossRef] [PubMed]
[15] Noble, D., Mathur, R., Dent, T., Meads, C. and Greenhalgh, T. (2011) Risk Models and Scores for Type 2 Diabetes: Systematic Review. BMJ, 343, d7163. [Google Scholar] [CrossRef] [PubMed]
[16] Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Niel-sen, T., Jensen, B.A.H., et al. (2016) Human Gut Microbes Impact Host Serum Metabolome and Insulin Sensitivity. Nature, 535, 376-381. [Google Scholar] [CrossRef] [PubMed]
[17] Cani, P.D., Bibiloni, R., et al. (2008) Changes in Gut Microbiota Control Metabolic Endotoxemia Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice. Diabetes, 57, 1470-1481. [Google Scholar] [CrossRef] [PubMed]
[18] Amyot, J., Semache, M., Ferdaoussi, M., Fontés, G. and Poitout, V. (2012) Lipopolysaccharides Impair Insulin Gene Expression in Isolated Is-Lets of Langerhans via Toll-Like Receptor-4 and NF-kappaB Signalling. PLOS ONE, 7, e36200. [Google Scholar] [CrossRef] [PubMed]
[19] Tolhurst, G., Heffron, H., Lam, Y.S., Parker, H.E., Habib, A.M., et al. (2012) Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2. Diabetes, 61, 364-371. [Google Scholar] [CrossRef] [PubMed]
[20] Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H. and Flier, J.S. (2006) TLR4 Links Innate Immunity and Fatty Acid-Induced Insulin Resistance. Journal of Clinical Investigation, 116, 3015-3025. [Google Scholar] [CrossRef
[21] Wang, T.J., et al. (2011) Metabolite Profiles and the Risk of Developing Diabetes. Nature Medicine, 17, 448-453. [Google Scholar] [CrossRef] [PubMed]
[22] El-Mesallamy, H.O., et al. (2011) Vaspin and Visfatin/Nampt Are Interesting Interrelated Adipokines Playing a Role in the Pathogenesis of Type 2 Diabetes Mellitus. Metabolism, 60, 63-70. [Google Scholar] [CrossRef] [PubMed]
[23] Perino, A., Pols, T.W.H., Nomura, M., Stein, S., Pellicciari, R. and Schoonjans, K. (2014) TGR5 Reduces Macrophage Migration through mTOR-Induced C/EBPbeta Differential Translation. Journal of Clinical Investigation, 124, 5424- 5436. [Google Scholar] [CrossRef
[24] Fang, S., et al. (2015) Intestinal FXR Agonism Promotes Adipose Tissue Browning and Reduces Obesity and Insulin Resistance. Nature Medicine, 21, 159-165. [Google Scholar] [CrossRef] [PubMed]
[25] Ettinger, G., MacDonald, K., Reid, G. and Burton, J.P. (2014) The Influence of the Human Microbiome and Probiotics on Cardiovascular Health. Gut Microbes, 5, 719-728. [Google Scholar] [CrossRef] [PubMed]
[26] Griffin, J.L., Wang, X. and Stanley, E. (2015) Does Our Gut Microbiome Predict Cardiovascular Risk? A Review of the Evidence from Metabolomics. Circula-tion-Cardiovascular Genetics, 8, 187-191. [Google Scholar] [CrossRef
[27] Emoto, T., Yamashita, T., Sasaki, N., Hirota, Y., Hayashi, T., So, A., Kasahara, K., Yodoi, K., Matsumoto, T., Mizoguchi, T., Ogawa, W. and Hirata, K. (2016) Analysis of Gut Microbiota in Coronary Artery Disease Patients: A Possible Link between Gut Microbiota and Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis, 23, 908-921. [Google Scholar] [CrossRef] [PubMed]
[28] Tang, W., Bäckhed, F., Landmesser, U., et al. (2019) Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review. JACC: Journal of the American College of Cardiol-ogy, 73, 2089-2210. [Google Scholar] [CrossRef] [PubMed]
[29] Kim, J.Y., Kim, H., Jung, B.J., Kim, N.R., Park, J.E. and Chung, D.K. (2013) Lipoteichoic Acid Isolated from Lactobacillus plantarum Suppresses LPS-Mediated Atherosclerotic Plaque Inflammation. Molecules and Cells, 35, 115-124. [Google Scholar] [CrossRef] [PubMed]
[30] Kanno, S., Nishio, H., Tanaka, T., et al. (2015) Activation of an Innate Immune Receptor, Nod1, Accelerates Atherogenesis in Apoe-/-mice. The Journal of Immunology, 194, 773-780. [Google Scholar] [CrossRef] [PubMed]
[31] Karlsson, F.H., Fåk, F., Nookaew, I., et al. (2012) Symptomatic Atherosclerosis Is Associated with an Altered Gut Metagenome. Nature Communications, 3, Article No. 1245. [Google Scholar] [CrossRef] [PubMed]
[32] Laman, J.D., Schoneveld, A.H., Moll, F.L., et al. (2002) Significance of Peptidoglycan, a Proinflammatory Bacterial Antigen in Atherosclerotic Arteries and Its Association with Vulnerable Plaques. The American Journal of Cardiology, 90, 119-123. [Google Scholar] [CrossRef
[33] Santisteban, M.M., Qi, Y., Zubcevic, J., et al. (2017) Hyper-tension-Linked Pathophysiological Alterations in the Gut. Circulation Research, 120, 312-323. [Google Scholar] [CrossRef
[34] Marques, F.Z., Nelson, E., Chu, P.Y., Horlock, D., Fiedler, A., Ziemann, M., Tan, J.K., Kuruppu, S., Rajapakse, N.W., El-Osta, A., Mackay, C.R. and Kaye, D.M. (2017) High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice. Circulation, 135, 964-977. [Google Scholar] [CrossRef
[35] Durgan, D.J., Ganesh, B.P., Cope, J.L., Ajami, N.J., Phillips, S.C., Petrosino, J.F., Hollister, E.B. and Bryan, R.M. (2016) Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension. Hypertension, 67, 469-474. [Google Scholar] [CrossRef
[36] Li, J., Zhao, F., Wang, Y., et al. (2017) Gut Mi-crobiota Dysbiosis Contributes to the Development of Hypertension. Microbiome, 5, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
[37] Khalesi, S., Sun, J., Buys, N. and Jayasinghe, R. (2014) Effect of Probiotics on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Hypertension, 64, 897-903. [Google Scholar] [CrossRef
[38] Wilck, N., Matus, M.G., Kearney, S.M., et al. (2017) Salt-Responsive Gut Commensal Modulates TH17 Axis and Disease. Nature, 551, 585-589. [Google Scholar] [CrossRef] [PubMed]
[39] Qi, Y.F., Aranda, J.M., Rodriguez, V., Raizada, M.K. and Pepine, C.J. (2015) Impact of Antibiotics on Arterial Blood Pressure in a Patient with Resistant Hypertension—A Case Report. In-ternational Journal of Cardiology, 201, 157-158. [Google Scholar] [CrossRef] [PubMed]
[40] Robinson, C.J. and Young, V.B. (2010) Antibiotic Administration Alters the Community Structure of the Gastrointestinal Microbiota. Gut Microbes, 1, 279-284. [Google Scholar] [CrossRef] [PubMed]
[41] Toya, T., Corban, M.T., Marrietta, E., et al. (2020) Coronary Arte-rydisease Is Associated with an Altered Gut Microbiome Composition. PLOS ONE, 15, e0227147. [Google Scholar] [CrossRef] [PubMed]
[42] Wang, Z.N., Klipfell, E., Bennett, B.J., et al. (2011) Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease. Nature, 472, 57-63. [Google Scholar] [CrossRef] [PubMed]
[43] Trøseid, M., Ueland, T., Hov, J.R., et al. (2015) Microbiota-Dependent Metabolite Trimethylamine-N-Oxide Is Associated with Disease Severity and Survival of Patients with Chronic Heart Failure. Journal of Internal Medicine, 277, 717-726. [Google Scholar] [CrossRef] [PubMed]
[44] Suzuki, T., et al. (2016) Trimethylamine N-Oxide and Prognosis in Acute Heart Failure. Heart, 102, 841-848. [Google Scholar] [CrossRef] [PubMed]
[45] Suzuki, T., Heaney, L.M., Jones, D.J., et al. (2017) Trimethyla-mine N-Oxide and Risk Stratification after Acute Myocardial Infarction. Clinical Chemistry, 63, 420-428. [Google Scholar] [CrossRef] [PubMed]
[46] Schuett, K., et al. (2017) Trimethylamine-N-Oxide and Heart Failure with Reduced versus Preserved Ejection Fraction. JACC: Journal of the American College of Cardiology, 70, 3202-3204. [Google Scholar] [CrossRef] [PubMed]
[47] Cavalcante, R.G.S., De Albuquerque, T.M.R., De Luna Freire, M.O., et al. (2019) The Probiotic Lactobacillus fermentum 296 Attenuates Cardiometabolic Disorders in High Fat Diet-Treated Rats. Nutrition, Metabolism & Cardiovascular Diseases, 29, 1408-1417. [Google Scholar] [CrossRef] [PubMed]
[48] Koeth, R.A., Wang, Z.N., Levison, B.S., et al. (2013) Intestinal Microbiota Metabolism of L-carnitine, a Nutrient in Red Meat, Promotes Atherosclerosis. Nature Medicine, 19, 576-585. [Google Scholar] [CrossRef] [PubMed]
[49] Monda, V., Villano, I., Messina, A., et al. (2017) Exercise Modifies the Gut Microbiota with Positive Health Effects. Oxidative Medicine and Cellular Longevity, 2017, Article ID: 3831972. [Google Scholar] [CrossRef] [PubMed]
[50] Juraschek, S.P., Miller, E.R., Weaver, C.M. and Appel, L.J. (2017) Ef-fects of Sodium Reduction and the DASH Diet in Elation to Baseline Blood Pressure. JACC: Journal of the American College of Cardiology, 70, 2841-2848. [Google Scholar] [CrossRef] [PubMed]
[51] Fujita, T. (2014) Mechanism of Salt-Sensitive Hypertension: Focus on Adrenal and Sympathetic Nervous Systems. The Journal of the American Society of Nephrology, 25, 1148-1155. [Google Scholar] [CrossRef
[52] Zhao, L.P., Niholson, J.K., Lu, A., Wang, Z.T., et al. (2012) Tar-geting the Human Genome-Microbiome Axis for Drug Discovery: Inspirations from Global Systems Biology and Tradi-tional Chinese Medicine. Journal of Proteome Research, 11, 3509-3519. [Google Scholar] [CrossRef] [PubMed]
[53] Lin, Z., Ye, W., Zu, X.P., Xie, H., Li, H., et al. (2018) Integrative Meta-bolic and Microbial Profiling on Patients with Spleen-Yang-Deficiency Syndrome. Scientific Reports, 8, Article 6619. [Google Scholar] [CrossRef] [PubMed]
[54] Shao, S., Wang, D., Zheng, W., et al. (2019) A Unique Poly-saccharide from Hericium erinaceus Mycelium Ameliorates Acetic Acid-Induced Ulcerative Colitis Rats by Modulating the Composition of the Gut Microbiota, Short Chain Fatty Acids Levels and GPR41/43 Respectors. International Im-munopharmacology, 71, 411-422. [Google Scholar] [CrossRef] [PubMed]
[55] Fan, S., Nie, S., Huang, X., et al. (2018) Protective Properties of Combined Fungal Polysaccharides from Cordyceps sinensis and Ganoderma atrum on Colon Immune Dysfunction. In-ternational Journal of Biological Macromolecules, 114, 1049-1055. [Google Scholar] [CrossRef] [PubMed]